Literature DB >> 30872389

Gellan Gum Based Sol-to-Gel Transforming System of Natamycin Transfersomes Improves Topical Ocular Delivery.

Karthik Yadav Janga1, Akshaya Tatke1, Narendar Dudhipala1, Sai Prachetan Balguri1, Mohamed Moustafa Ibrahim1, Doaa Nabih Maria1, Monica M Jablonski1, Soumyajit Majumdar2.   

Abstract

Short precorneal residence time and poor transocular membrane permeability are the major challenges associated with topical ocular drug delivery. In the present research, the efficiency of the electrolyte-triggered sol-to-gel-forming system of natamycin (NT) transfersomes was investigated for enhanced and prolonged ophthalmic delivery. Transfersomes were optimized by varying the molar ratios of phospholipid, sorbitan monostearate (Span) and tocopheryl polyethylene glycol succinate (TPGS). NT transfersome formulations (FNs) prepared with a 1:1 molar ratio of phospholipid-to-Span and low levels of TPGS showed optimal morphometric properties, and were thus selected to fabricate the in situ gelling system. Gellan gum-based (0.3% w/v) FN-loaded formulations (FNGs) immediately formed an in situ gel in the simulated tear fluid, with considerable viscoelastic characteristics. In vitro cytotoxicity in corneal epithelial cells and corneal histology studies demonstrated the ocular safety and cytocompatibility of these optimized formulations. Transcorneal permeability of NT from these formulations was significantly higher than in the control suspension. Moreover, the ocular disposition studies of NT, from the FNs and FNGs, in New Zealand male albino rabbits demonstrated the superiority of the electrolyte-sensitive FNGs in terms of NT delivery to the ocular tissues.
Copyright © 2019 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Year:  2019        PMID: 30872389      PMCID: PMC6806353          DOI: 10.1124/jpet.119.256446

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  42 in total

Review 1.  Challenges and obstacles of ocular pharmacokinetics and drug delivery.

Authors:  Arto Urtti
Journal:  Adv Drug Deliv Rev       Date:  2006-09-26       Impact factor: 15.470

2.  Investigating the potential of employing bilosomes as a novel vesicular carrier for transdermal delivery of tenoxicam.

Authors:  Abdulaziz M Al-Mahallawi; Aly A Abdelbary; Mona H Aburahma
Journal:  Int J Pharm       Date:  2015-03-18       Impact factor: 5.875

3.  Texture analysis of cosmetic/pharmaceutical raw materials and formulations.

Authors:  A Tai; R Bianchini; J Jachowicz
Journal:  Int J Cosmet Sci       Date:  2014-06-30       Impact factor: 2.970

Review 4.  Bilosomes in the context of oral immunization: development, challenges and opportunities.

Authors:  Anshuman Shukla; Vijay Mishra; Prashant Kesharwani
Journal:  Drug Discov Today       Date:  2016-03-30       Impact factor: 7.851

Review 5.  Ethosomes and Transfersomes: Principles, Perspectives and Practices.

Authors:  Varun Garg; Harmanpreet Singh; Sneha Bimbrawh; Sachin Kumar Singh; Monica Gulati; Yogyata Vaidya; Prabhjot Kaur
Journal:  Curr Drug Deliv       Date:  2017       Impact factor: 2.565

6.  Ocular drug delivery systems: An overview.

Authors:  Ashaben Patel; Kishore Cholkar; Vibhuti Agrahari; Ashim K Mitra
Journal:  World J Pharmacol       Date:  2013

7.  Fabrication of novel ultradeformable bilosomes for enhanced ocular delivery of terconazole: In vitro characterization, ex vivo permeation and in vivo safety assessment.

Authors:  Aly A Abdelbary; Wessam H Abd-Elsalam; Abdulaziz M Al-Mahallawi
Journal:  Int J Pharm       Date:  2016-10-04       Impact factor: 5.875

8.  Nanoemulsion-based electrolyte triggered in situ gel for ocular delivery of acetazolamide.

Authors:  Nadia Morsi; Magdy Ibrahim; Hanan Refai; Heba El Sorogy
Journal:  Eur J Pharm Sci       Date:  2017-04-19       Impact factor: 4.384

9.  Efficacy and safety of epicutaneous ketoprofen in Transfersome (IDEA-033) versus oral celecoxib and placebo in osteoarthritis of the knee: multicentre randomised controlled trial.

Authors:  Matthias Rother; Bernard J Lavins; Werner Kneer; Klaus Lehnhardt; Egbert J Seidel; Stefan Mazgareanu
Journal:  Ann Rheum Dis       Date:  2007-03-15       Impact factor: 19.103

10.  Formulation and evaluation of voriconazole ophthalmic solid lipid nanoparticles in situ gel.

Authors:  Dinesh Kumar Pandurangan; Prathima Bodagala; Vijayaraj Kumar Palanirajan; Saravanan Govindaraj
Journal:  Int J Pharm Investig       Date:  2016 Jan-Mar
View more
  10 in total

Review 1.  Transfersomes: a Revolutionary Nanosystem for Efficient Transdermal Drug Delivery.

Authors:  Muhammad Waseem Akram; Humzah Jamshaid; Fiza Ur Rehman; Muhammad Zaeem; Jehan Zeb Khan; Ahmad Zeb
Journal:  AAPS PharmSciTech       Date:  2021-12-01       Impact factor: 3.246

2.  Dual Drug Loaded Lipid Nanocarrier Formulations for Topical Ocular Applications.

Authors:  Ahmed Adel Ali Youssef; Narendar Dudhipala; Soumyajit Majumdar
Journal:  Int J Nanomedicine       Date:  2022-05-18

3.  Nanocubosomal based in situ gel loaded with natamycin for ocular fungal diseases: development, optimization, in-vitro, and in-vivo assessment.

Authors:  Khaled M Hosny; Waleed Y Rizg; Hala M Alkhalidi; Walaa A Abualsunun; Rana B Bakhaidar; Alshaimaa M Almehmady; Adel F Alghaith; Sultan Alshehri; Amani M El Sisi
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.819

4.  Gellan gum-based in situ gelling ophthalmic nanosuspension of Posaconazole.

Authors:  Purva Khare; Manasi M Chogale; Pratik Kakade; Vandana B Patravale
Journal:  Drug Deliv Transl Res       Date:  2022-05-10       Impact factor: 5.671

5.  QbD based development of HPLC method for simultaneous quantification of Telmisartan and Hydrochlorothiazide impurities in tablets dosage form.

Authors:  Ashok K Palakurthi; Thirupathi Dongala; Lakshmi Narasimha R Katakam
Journal:  Pract Lab Med       Date:  2020-06-01

6.  Enhanced Corneal Penetration of a Poorly Permeable Drug Using Bioadhesive Multiple Microemulsion Technology.

Authors:  Mohamed Moustafa Ibrahim; Doaa Nabih Maria; XiangDi Wang; Raven N Simpson; T J Hollingsworth; Monica M Jablonski
Journal:  Pharmaceutics       Date:  2020-07-26       Impact factor: 6.321

7.  The Antifungal and Ocular Permeation of Ketoconazole from Ophthalmic Formulations Containing Trans-Ethosomes Nanoparticles.

Authors:  Tarek A Ahmed; Maram M Alzahrani; Alaa Sirwi; Nabil A Alhakamy
Journal:  Pharmaceutics       Date:  2021-01-24       Impact factor: 6.321

8.  In vivo and in vitro Evaluation of in situ Gel Formulation of Pemirolast Potassium in Allergic Conjunctivitis.

Authors:  Ting Shen; Zijian Yang
Journal:  Drug Des Devel Ther       Date:  2021-05-18       Impact factor: 4.162

Review 9.  Recent Advances in the Development of In Situ Gelling Drug Delivery Systems for Non-Parenteral Administration Routes.

Authors:  Barbara Vigani; Silvia Rossi; Giuseppina Sandri; Maria Cristina Bonferoni; Carla M Caramella; Franca Ferrari
Journal:  Pharmaceutics       Date:  2020-09-10       Impact factor: 6.321

Review 10.  Lipid-Based Nanovesicular Drug Delivery Systems.

Authors:  Tania Limongi; Francesca Susa; Monica Marini; Marco Allione; Bruno Torre; Roberto Pisano; Enzo di Fabrizio
Journal:  Nanomaterials (Basel)       Date:  2021-12-14       Impact factor: 5.076

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.